Matthew Thompson

Matthew Thompson is a declared insider of Endologix Inc /DE/, with filings sourced from SEC (Form 4). The record holds 15 filings, for trades running from 15 May 2018 to 12 August 2020.

No open-market purchase appears, only 1 sale worth €1,633. The rest of the record consists of 11 share grants. In 2020 alone, the filings show no purchases and 1 sale.

The newest entry dates from 14 August 2020: an open-market sale of €1,633, in Endologix Inc /DE/. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.